Um die volle Funktionalität der Webseite nutzen zu können, müssen Sie JavaScript in ihrem Browser aktivieren.

DAX23.155,75-0,66 %

Gold3.367,30-0,05 %

Öl (Brent)77,52+1,60 %

Dow Jones41.891,47-0,63 %

US Tech 10021.536,44-0,81 %

EUR/USD1,14812-0,03 %

Top 15 der gesamten Suchanfragen der letzten 7 Tage

Login

Mural Oncology Registred Aktie

Aktie

ISIN: IE000LK2BOB4 WKN: A3EE4M SYM: MURA Land Flagge IE

Irland

Zur Watchlist hinzufügen Zum Portfolio hinzufügen

Zum Portfolio hinzufügen

2,4700

USD

+1,23 %

+0,0300 USD

Letzter Kurs 02:00:00 Nasdaq

Mural Oncology Registred Aktie kaufen

Geldkurs

18.06.25

2,4400

USD

2.400 STK

Briefkurs

18.06.25

2,4800

USD

6.100 STK

BEI SMARTBROKER+ HANDELN

Handeln über unsere
Partner-Broker

Brokerize

Neueste Nachrichten

Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 18.06.25 · EQS Group AG · Mural Oncology Registred
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 17.06.25 · EQS Group AG · Mural Oncology Registred
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 16.06.25 · EQS Group AG · Mural Oncology Registred
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 13.06.25 · EQS Group AG · Mural Oncology Registred
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 11.06.25 · EQS Group AG · Mural Oncology Registred
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology PLC 10.06.25 · EQS Group AG · Mural Oncology Registred
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 06.06.25 · EQS Group AG · Mural Oncology Registred
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 05.06.25 · EQS Group AG · Mural Oncology Registred
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 04.06.25 · EQS Group AG · Mural Oncology Registred
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 03.06.25 · EQS Group AG · Mural Oncology Registred
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 02.06.25 · EQS Group AG · Mural Oncology Registred
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 30.05.25 · EQS Group AG · Mural Oncology Registred

1
2
3
4
…
5

Meistgelesen

24 Stunden
7 Tage
30 Tage
12 Monate

Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 104 Leser

Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 112 Leser
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 108 Leser
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 104 Leser
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 104 Leser

Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 120 Leser
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 116 Leser
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 112 Leser
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 112 Leser
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 112 Leser
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 112 Leser
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 108 Leser
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 108 Leser
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc 108 Leser
Form 8.3 - The Vanguard Group, Inc.: Mural Oncology PLC 108 Leser

Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 432 Leser
Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 392 Leser
Mural Oncology to Present at Two Upcoming Investor Conferences 376 Leser
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline ... 356 Leser
Mural Oncology to Host First Virtual Investor Day on September 26, 2024 264 Leser
Mural Oncology Highlights Pipeline Progress and Anticipated 2025 Catalysts 228 Leser
Mural Oncology Provides Update on Phase 3 ARTISTRY-7 Trial of Nemvaleukin in Combination with ... 212 Leser
Mural Oncology Appoints Veteran Business Development Executive George Golumbeski, Ph.D., to its ... 164 Leser
Mural Oncology Presents Clinical and Preclinical Data Across its Pipeline at the 39th Annual ... 152 Leser
Mural Oncology Announces Third Quarter 2024 Financial Results and Provides Update on Pipeline ... 152 Leser